The University of Illinois Hospital & Health Sciences System is a member of the Illinois Medical District, one of the largest urban healthcare, educational, research, and technology districts in the USA.

There are 485 beds in University of Illinois at Chicago Health Sciences Center.

During the past decade, University of Illinois at Chicago Health Sciences Center conducted 56 clinical trials. In the 10-year time frame, 56 clinical trials started and 39 clinical trials were completed, i.e. on average, 69.6% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 24 clinical trials were completed. i.e. 92.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Illinois at Chicago Health Sciences Center" #1 sponsor was "University of Illinois at Chicago" with 32 trials, followed by "Alliance for Clinical Trials in Oncology" with 23 trials sponsored, "Jaeb Center for Health Research" with 10 trials sponsored, "Children's Oncology Group" with 8 trials sponsored and "United Therapeutics" with 8 trials sponsored. Other sponsors include 59 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Illinois at Chicago Health Sciences Center" #1 collaborator was "National Cancer Institute (NCI)" with 42 trials as a collaborator, "National Eye Institute (NEI)" with 9 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 7 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 113 different institutions and companies that were collaborators in the rest 93 trials.

According to Clinical.Site data, the most researched conditions in "University of Illinois at Chicago Health Sciences Center" are "Leukemia" (8 trials), "Pulmonary Hypertension" (8 trials), "Heart Failure" (7 trials), "Lung Cancer" (7 trials) and "Diabetic Macular Edema" (5 trials). Many other conditions were trialed in "University of Illinois at Chicago Health Sciences Center" in a lesser frequency.

Most popular intervention types in "University of Illinois at Chicago Health Sciences Center" are "Drug" (93 trials), "Biological" (22 trials), "Behavioral" (16 trials), "Procedure" (16 trials) and "Device" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "radiation therapy" (12 trials), "cyclophosphamide" (9 trials), "carboplatin" (7 trials) and "paclitaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "University of Illinois at Chicago Health Sciences Center" are 131 trials for "All" genders, 7 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "University of Illinois at Chicago Health Sciences Center". 2 are not yet recruiting, 13 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 91 completed trials in University of Illinois at Chicago Health Sciences Center, undefined suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in University of Illinois at Chicago Health Sciences Center, 13 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 55 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 25 trials that are defined as “Not Applicable".

University of Illinois at Chicago Health Sciences Center has several departments that took part in Clinical trials: "University of Illinois Cancer Center" - 114 trials, "Univ. of Illinois Family Ctr. for Infectious Disease CRS" - 4 trials, "Children's Hospital of the University of Illinois" - 2 trials